Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1

Blood

Volumn 97, Issue 9, 2001, Pages 2879-2885

  Moulds, Joann M ^{a,b,c,d,e,f,g,h,i}   Zimmerman, Peter A ^{a,b,c,d,e,f,g,h}   Doumbo, Ogobara K ^{a,b,c,d,e,f,g,h}   Kassambara, Lalla ^{a,b,c,d,e,f,g,h}   Sagara, Issaka ^{a,b,c,d,e,f,g,h}   Diallo, Dapa A ^{a,b,c,d,e,f,g,h}   Atkinson, John P ^{a,b,c,d,e,f,g,h}   Krych Goldberg, Malgorzata ^{a,b,c,d,e,f,g,h}   Hauhart, Richard E ^{a,b,c,d,e,f,g,h}   Hourcade, Dennis E ^{a,b,c,d,e,f,g,h}   McNamara, David T ^{a,b,c,d,e,f,g,h}   Birmingham, Daniel J ^{a,b,c,d,e,f,g,h}   Alexandra Rowe, J ^{a,b,c,d,e,f,g,h}   Moulds, John J ^{a,b,c,d,e,f,g,h}   Miller, Louis H ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF BAMAKO   (Mali)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g Ortho McNeil Pharmaceutical Incorporated   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; DNA; EPITOPE; MONOCLONAL ANTIBODY;

ALLELE; ARTICLE; BLOOD GROUP; BLOOD SAMPLING; COMPLEMENT SYSTEM; DNA SEQUENCE; ERYTHROCYTE; EXON; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; PEDIGREE ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0035353197     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.9.2879     Document Type: Article

References (30)

1. Ahearn JA, Fearon DT. Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv Immunol. 1989;46:183-219.
2. Rowe A, Moulds JM, Newbold CI, Miller LH, P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature. 1997;388:292-295.
3. Carlson J, Helmby H, Hill AVS, Brewster D, Greenwood BM, Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet. 1990;336:1457-1460.
4. Kun JFJ, Schmidt-Ott RJ, Lehman LG, et al. Merozoite surface antigen 1 and 2 genotypes and rosetting Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans R Soc Trop Med Hyg. 1998;92:110-114.
5. Rowe JA, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun. 1995;63:2323-2326.
6. Treutiger CJ, Hedlund I, Helmby H, et al. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg. 1992;46:503-510.
7. Hourcade D, Miesner DR, Bee C, Zeldes W, Atkinson JP. Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. J Biol Chem. 1990;265:974-980.
8. Cohen JHM, Atkinson JP, Klickstein LB, Oudin S, Subramanian B, Moulds JM. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms. Mol Immunol. 1999;36:819-825.
9. Moulds JM, Moulds JJ, Brown M, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/ Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang. 1992;62:230-235.
10. Helgeson M, Swanson J, Polesky HF. Knops-Helgeson (Kna), a high frequency erythrocyte antigen. Transfusion. 1970;10:137-138.
11. Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med. 1986;164:50-59.
12. Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type one (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol. 1999;87:176-183.
13. Moulds JM, Nickells MW, Moulds JJ, Brown M, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley and York blood group antisera. J Exp Med. 1991;173:1159-1163.
14. Rao N, Ferguson DJ, Lee S-F, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol. 1991;146:3502-3507.
15. Daniels G. Human Blood Groups. Oxford, United Kingdom: Blackwell Science; 1995.
16. Moulds JM, Kassambara L, Middleton JJ, et al. Identification of complement receptor one (CR1) polymorphisms in West Africa. Genes Immunity. 2000;1:325-329.
17. Zimmerman PA, Dadzie KY, DeSole G, Remme J, Alley ES, Unnasch TR. Onchocerca volvulus DNA probe classification correlates with epidemiologic patterns of blindness. J Infect Dis. 1992;65:964-968.
18. Walker RH, ed. Technical Manual. 10th ed. Arlington, Va: American Association of Blood Banks; 1990.
19. Quadri RA, Schifferli JA. Over-estimation of the number of complement receptor type 1 (CR1) on erythrocytes. Scand J Immunol. 1992;36:125-130.
20. Nickells M, Hauhart R, Krych M, et al. Mapping epitopes for 20 monoclonal antibodies to CR1. Clin Exp Immunol. 1998;112:27-33.
21. Moulds JM, Brai M, Cohen J, et al. Reference typing report for complement receptor one (CR1). Exp Clin Immunogenet. 1998;15:291-294.
22. Krych-Goldberg M, Hauhart EL, Subramanian BV, et al. Decay accelerating activity of complement receptor type one (CD35): two active sites are required for dissociating C5 convertases. J Biol Chem. 1999;274:31160-31168.
23. Moulds JM, Rowe K. Neutralization of Knops system antibodies using soluble complement receptor one. Transfusion. 1996;36:517-520.
24. Weir BS. Genetic Data Analysis. Sunderland, MA: Sinauer; 1996.
25. Molthan L. Expansion of the York, Cost, McCoy, Knops blood group system: the new McCoy antigens McCc and McCd. Med Lab Sci. 1983;40:113-121.
26. Xiang L, Rundles JR, Hamilton DR, Wilson JG. Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. J Immunol. 2000;163:4939-4945.
27. Ross GD, Yount WJ, Walport MJ, et al. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation. J Immunol. 1985;135:2005-2014.
28. Corvetta A, Pomponio G, Bencivenga R, et al. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy. J Rheumatol. 1991;18:1021-1025.
29. Van Dyne S, Holers VM, Lublin DM, Atkinson JP. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus. Clin Exp Immunol. 1987;68:570-579.
30. Yu CY, Campbell RD, Porter RR. A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement component C4A/C4B isotypes. Immunogenetics. 1988;27:399-405.